Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1775 (LINC01775) is a member of the long intergenic non-coding RNA (lincRNA) family. LincRNAs are autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap with annotated protein-coding genes. They primarily act at the transcriptional and epigenetic level, with functions including remodeling of chromatin, regulating gene expression, RNA stabilization, and influencing transcriptional machinery. LincRNAs can have tissue-specific expression and serve as fine-tuners of nearby gene expression, sometimes exhibiting enhancer-like activities. While numerous lincRNAs have been linked to disease states such as cancer, there is currently no specific data about LINC01775’s involvement in a particular disease, its candidacy as a therapeutic target, or any known drug interactions[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1775 (LINC01775).